KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMortgage LoansNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsRaw MaterialsReal Estate - GrossReal Estate - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CTO Realty Growth (CTO) Accumulated Expenses (2016 - 2025)

CTO Realty Growth has reported Accumulated Expenses over the past 15 years, most recently at $690000.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $690000.0 for Q4 2025, down 39.1% from a year ago — trailing twelve months through Dec 2025 was $690000.0 (down 39.1% YoY), and the annual figure for FY2025 was $690000.0, down 39.1%.
  • Accumulated Expenses for Q4 2025 was $690000.0 at CTO Realty Growth, down from $5.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CTO hit a ceiling of $20.0 million in Q1 2025 and a floor of $491000.0 in Q2 2021.
  • Median Accumulated Expenses over the past 5 years was $1.8 million (2022), compared with a mean of $5.6 million.
  • Biggest five-year swings in Accumulated Expenses: soared 2007.0% in 2023 and later crashed 93.83% in 2024.
  • CTO Realty Growth's Accumulated Expenses stood at $4.0 million in 2021, then plummeted by 78.11% to $872000.0 in 2022, then soared by 2007.0% to $18.4 million in 2023, then crashed by 93.83% to $1.1 million in 2024, then crashed by 39.1% to $690000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $690000.0 (Q4 2025), $5.2 million (Q3 2025), and $655000.0 (Q2 2025) per Business Quant data.